What is LUCY's earnings growth forecast for 2026-2026?
(NASDAQ: LUCY) Innovative Eyewear's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Innovative Eyewear's earnings in 2026 is -$7,847,192.
In 2026, LUCY is forecast to generate -$5,620,902 in earnings, with the lowest earnings forecast at -$5,400,475 and the highest earnings forecast at -$5,786,223.
What is LUCY's revenue growth forecast for 2026-2026?
(NASDAQ: LUCY) Innovative Eyewear's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Innovative Eyewear's revenue in 2026 is $2,392,547.
In 2026, LUCY is forecast to generate $49,114,680 in revenue, with the lowest revenue forecast at $47,188,614 and the highest revenue forecast at $50,559,229.
What is LUCY's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: LUCY) forecast ROA is -50.3%, which is lower than the forecast US Medical Instruments & Supplies industry average of 12.57%.
What is LUCY's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: LUCY) Innovative Eyewear's current Earnings Per Share (EPS) is -$2.17. In 2026, LUCY's EPS is forecast to hit -$1.05 (min: -$1.01, max: -$1.08).
What is LUCY's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: LUCY) forecast ROE is -54.84%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.